Abstract
Ocular nonnephropathic cystinosis, a variant of the classic nephropathic type of cystinosis, is an autosomal recessive lysosomal storage disorder characterized by photophobia due to corneal cystine crystals but absence of renal disease. We determined the molecular basis for ocular cystinosis in four individuals. All had mutations in the cystinosis gene CTNS, indicating that ocular cystinosis is allelic with classic nephropathic cystinosis. The ocular cystinosis patients each had one severe mutation and one mild mutation, the latter consisting of either a 928 G→A (G197R) mutation or an IVS10–3 C→G splicing mutation resulting in the insertion of 182 bp of IVS10 into the CTNS mRNA. The mild mutations appear to allow for residual CTNS mRNA production, significant amounts of lysosomal cystine transport, and lower levels of cellular cystine compared with those in nephropathic cystinosis. The lack of kidney involvement in ocular cystinosis may be explained by two different mechanisms. On the one hand (e.g. the G197R mutation), significant residual cystinosin activity may be present in every tissue. On the other hand (e.g. the IVS10–3 C→G mutation), substantial cystinosin activity may exist in the kidney because of that tissue's specific expression of factors that promote splicing of a normal CTNS transcript. Each of these mechanisms could result in minimally reduced lysosomal cystine transport in the kidneys.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- SSCP:
-
single-stranded conformational polymorphism
- RT-PCR:
-
reverse-transcription polymerase chain reaction
References
Gahl WA, Schneider JA, Aula P 1995 Lysosomal transport disorders: cystinosis and sialic acid storage disorders. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The Metabolic and Molecular Bases of Inherited Disease, 7th Ed. McGraw-Hill, New York, 3763–3797.
Gahl WA 1986 Cystinosis coming of age. Adv Pediatr 33: 95–126.
Gahl WA, Kaiser-Kupfer MI 1987 Complications of nephropathic cystinosis after renal failure. Pediatr Nephrol 1: 260–268.
Gahl WA, Dalakas M, Charnas L, Chen KTK, Pezeshkpour GH, Kuwabara T, Davis SL, Chesney RW, Fink J, Hutchison HT 1988 Myopathy and cystine storage in muscles in patients with nephropathic cystinosis. N Engl J Med 319: 1461–1464.
Charnas LR, Luciano CA, Dalakas M, Gilliat RW, Bernardini I, Ishak K, Swik VA, Fraker D, Brushart TA, Gahl WA 1994 Distal vacuolar myopathy in nephropathic cystinosis. Ann Neurol 35: 181–188.
Sonies BC, Ekman EF, Andersson HC, Adamson MD, Kaler SG, Markello TC, Gahl WA 1990 Swallowing dysfunction in nephropathic cystinosis. N Engl J Med 323: 565–570.
Fivush B, Green OC, Porter CC, Balfe JW, O'Regan S, Gahl WA 1987 Pancreatic endocrine insufficiency in post-transplant cystinosis. Am J Dis Child 141: 1087–1089.
Fivush B, Flick JA, Gahl WA 1988 Pancreatic exocrine insufficiency in a patient with nephropathic cystinosis. J Pediatr 112: 49–51.
Ehrich JHHH, Stoeppler L, Offner G, Brodehl J 1979 Evidence for cerebral involvement in nephropathic cystinosis. Neuropaediatrie 10: 128–137.
Fink JK, Brouwers P, Barton N, Malekzadeh MH, Sato S, Hill S, Cohen WE, Fivush B, Gahl WA 1989 Neurologic complications in longstanding nephropathic cystinosis. Arch Neurol 46: 543–548.
Chik CL, Friedman A, Merriam GR, Gahl WA 1993 Pituitary-testicular function in nephropathic cystinosis. Ann Intern Med 119: 568–575.
Kaiser-Kupfer MI, Caruso RC, Minckler DS, Gahl WA 1986 Long-term ocular manifestations in nephropathic cystinosis post-renal transplantation. Arch Ophthal 104: 706–711.
Thoene J, Oshima R, Crawhall J, Olson D, Schneider J 1976 Cystinosis: intracellular cystine depletion by aminothiols in vitro and vivo. J Clin Invest 58: 180–189.
Gahl WA, Reed GF, Thoene JG, Schulman JD, Rizzo WB, Jonas AJ, Denman DW, Schlesselman JJ, Corden BJ, Schneider JA 1987 Cysteamine therapy for children with nephropathic cystinosis. N Engl J Med 316: 971–977.
Markello TC, Bernardini IM, Gahl WA 1993 Improved renal function in children with cystinosis treated with cysteamine. N Engl J Med 328: 1157–1162.
Kimonis VE, Troendle J, Rose SR, Yang ML, Markello TC, Gahl WA 1995 Effects of early cysteamine therapy on thyroid function and growth in nephropathic cystinosis. J Clin Endocrinol Metab 80: 3257–3261.
Gahl WA, Charnas L, Markello TC, Bernardini I, Ishak KG, Dalakas MC 1992 Parenchymal organ cystine depletion with long term cysteamine therapy. Biochem Med Metab Biol 48: 275–285.
Kaiser-Kupfer MI, Fujikawa L, Kuwabara T, Jain S, Gahl WA 1987 Removal of corneal crystals by topical cysteamine in nephropathic cystinosis. N Engl J Med 316: 775–779.
Kaiser-Kupfer MI, Gazzo MA, Datiles MB, Caruso RC, Kuehl EM, Gahl WA 1990 A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis. Arch Ophthalmol 108: 689–693.
Cogan DG, Kuwabara T, Kinoshita J, Sheehan L, Merola L 1957 Cystinosis in an adult. JAMA 164: 394–396.
Pellet OL, Smith ML, Greene AA, Schneider JA 1988 Lack of complementation in somatic cell hybrids between fibroblasts from patients with different forms of cystinosis. Proc Natl Acad Sci USA 85: 3531–3534.
Gahl WA, Tietze F, Bashan N, Steinherz R, Schulman JD 1982 Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem 257: 9570–9575.
Gahl WA, Bashan N, Tietze F, Bernardini I, Schulman JD 1982 Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis. Science 217: 1263–1265.
Jonas AJ, Smith ML, Schneider JA 1982 ATP-dependent lysosomal cystine efflux is defective in cystinosis. J Biol Chem 257: 13185–13188.
Gahl WA, Tietze F, Bashan N, Bernardini I, Schulman JD 1983 Characteristics of cystine counter-transport in normal and cystinotic lysosome-rich leucocyte granular fractions. Biochem J 216: 393–400.
The Cystinosis Collaborative Research Group 1995 Linkage of the gene for cystinosis to markers on the short arm of chromosome 17. Nat Genet 10: 246–248.
Town M, Jean G, Cherqui S, Attard M, Forestier L, Whitmore SA, Callen DF, Gribouval O, Broyer M, Bates GP, van't Hoff W, Antignac C 1998 A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nat Genet 18: 319–324.
Shotelersuk V, Larson D, Anikster Y, McDowell G, Lemons R, Bernardini I, Guo J, Thoene J, Gahl WA 1998 CTNS mutations in an American-based population of cystinosis patients. Am J Hum Genet 63: 1352–1362.
Anikster Y, Lucero C, Touchman JW, Huizing M, McDowell G, Shotelersuk V, Green ED, Gahl WA 1999 Identification and detection of the common 65-kb deletion breakpoint in the nephropathic cystinosis gene (CTNS). Mol Genet Metab 66: 111–116.
Oshima RG, Willis RC, Furlong CE, Schneider JA 1974 Binding assays for amino acids. J Biol Chem 249: 6033–6039.
Charnas LR, Bernardini I, Rader D, Hoeg JM, Gahl WA 1991 Clinical and laboratory findings in the oculocerebrorenal syndrome of Lowe, with special reference to growth and renal function. N Engl J Med 324: 1318–1325.
Gahl WA, Tietze F 1987 Lysosomal cystine transport in cystinosis variants and their parents. Pediatr Res 21: 193–196.
Wong C, Antonarakis SE, Goff SC, Orkin SH, Forget BG, Nathan DG, Giardina PJ, Kazazian HH 1989 Beta-thalassemia due to two novel nucleotide substitutions in consensus acceptor splice sequences of the beta-globin gene. Blood 73: 914–918.
Ieiri T, Cochaux P, Targovnik HM, Suzuki M, Shimoda S, Perret J, Vassart G 1991 A 3′ splice site mutation in the thyroglobulin gene responsible for congenital goiter with hypothyroidism. J Clin Invest 88: 1901–1905.
Holzl B, Huber R, Paulweber B, Patsch JR, Sandhofer F 1994 Lipoprotein lipase deficiency due to a 3′ splice site mutation in intron 6 of the lipoprotein lipase gene. J Lipid Res 35: 2161–2169.
Jaruzelska J, Abadie V, d'Aubenton-Carafa Y, Brody E, Munnich A, Marie J 1995 In vitro splicing deficiency induced by a C to T mutation at position −3 in the intron 10 acceptor site of the phenylalanine hydroxylase gene in a patient with phenylketonuria. J Biol Chem 270: 20370–20375.
Krawczak M, Reiss J, Cooper DN 1992 The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90: 41–54.
Chiba-Falek O, Nissim-Rafinia M, Kerem B 1998 Regulation of CFTR alternative splicing in vivo by overexpression of cellular and viral splicing factors. Am J Hum Genet 63: A356–A359
Harper GS, Kohn LD, Bernardini I, Bernar J, Tietze F, Andersson H, Gahl WA 1988 Thyrotropin stimulates lysosomal tyrosine transport in rat FRTL-5 thyroid cells. J Biol Chem 263: 9320–9325.
Acknowledgements
Dr. Yair Anikster is a Howard Hughes Medical Institute Physician Postdoctoral Fellow. The authors thank Mr. Ernest Kuehl of the National Eye Institute for superb ophthalmic photography. Cases 3 and 4 were astutely diagnosed and kindly referred by Dr. Walter Beebe of Dallas, Texas.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anikster, Y., Lucero, C., Guo, J. et al. Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations. Pediatr Res 47, 17 (2000). https://doi.org/10.1203/00006450-200001000-00007
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-200001000-00007
This article is cited by
-
Molecular characterization of CTNS mutations in Tunisian patients with ocular cystinosis
Diagnostic Pathology (2022)
-
A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
Orphanet Journal of Rare Diseases (2021)
-
Slow progression of renal failure in a child with infantile cystinosis
CEN Case Reports (2018)
-
Latest Clinical Approaches in the Ocular Management of Cystinosis: A Review of Current Practice and Opinion from the Ophthalmology Cystinosis Forum
Ophthalmology and Therapy (2018)
-
Mutation analysis of the CTNS gene in Iranian patients with infantile nephropathic cystinosis: identification of two novel mutations
Human Genome Variation (2017)
